CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.041
https://www.valueinhealthjournal.com/article/S1098-3015(17)30375-3/fulltext
Title : CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30375-3&doi=10.1016/j.jval.2017.08.041
First page : A405
Section Title : BREAKOUT SESSION VIII
Open access? : No
Section Order : 35
Categories :
Tags :
Regions :
ViH Article Tags :